- Home
- GSIW vs DRIO Comparison
GSIW vs DRIO Comparison
Compare GSIW & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSIW
- DRIO
- Stock Information
- Founded
- GSIW 2016
- DRIO 2011
- Country
- GSIW Hong Kong
- DRIO United States
- Employees
- GSIW N/A
- DRIO N/A
- Industry
- GSIW
- DRIO Medical/Dental Instruments
- Sector
- GSIW
- DRIO Health Care
- Exchange
- GSIW Nasdaq
- DRIO Nasdaq
- Market Cap
- GSIW 27.2M
- DRIO 30.5M
- IPO Year
- GSIW 2023
- DRIO N/A
- Fundamental
- Price
- GSIW $1.75
- DRIO $0.70
- Analyst Decision
- GSIW
- DRIO Strong Buy
- Analyst Count
- GSIW 0
- DRIO 2
- Target Price
- GSIW N/A
- DRIO $2.50
- AVG Volume (30 Days)
- GSIW 2.6M
- DRIO 146.0K
- Earning Date
- GSIW 01-01-0001
- DRIO 08-07-2025
- Dividend Yield
- GSIW N/A
- DRIO N/A
- EPS Growth
- GSIW N/A
- DRIO N/A
- EPS
- GSIW N/A
- DRIO N/A
- Revenue
- GSIW $1,313,795.00
- DRIO $28,034,000.00
- Revenue This Year
- GSIW N/A
- DRIO $20.85
- Revenue Next Year
- GSIW N/A
- DRIO $17.09
- P/E Ratio
- GSIW N/A
- DRIO N/A
- Revenue Growth
- GSIW N/A
- DRIO 47.20
- 52 Week Low
- GSIW $0.35
- DRIO $0.50
- 52 Week High
- GSIW $12.30
- DRIO $1.55
- Technical
- Relative Strength Index (RSI)
- GSIW 72.13
- DRIO 49.08
- Support Level
- GSIW $1.26
- DRIO $0.67
- Resistance Level
- GSIW $1.66
- DRIO $0.74
- Average True Range (ATR)
- GSIW 0.14
- DRIO 0.03
- MACD
- GSIW -0.02
- DRIO 0.00
- Stochastic Oscillator
- GSIW 92.25
- DRIO 42.86
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.